Pharmacokinetic Aspects of Epidural Morphine Analgesia

Publisher Website
Google Scholar
Abstract
Twenty patients undergoing thoracotomy were given 2, 4 or 6 mg morphine epidurally in a double-blind, randomized study for postoperative analgesia. Administration at T12-L1 or L1-L2 resulted in a dose-related analgetic duration (514 .+-. 118 min, 778 .+-. 207 min and 938 .+-. 155 min; means .+-. SEM [standard error of the mean], respectively, for the groups). For the 3 groups, peak plasma morphine concentrations (range 19-34 ng/ml) were reached within 15 min. The plasma curves had a similar appearance as after an i.m. injection and pharmacokinetic calculations showed an elimination half-life (mean .+-. SEM) of 173 .+-. 24 min, 200 .+-. 60 min and 213 .+-. 57 min for the groups, respectively. The morphine concentrations in the CSF were considerably higher compared with plasma (45-100 times the plasma concentration at 1 h, 100-250 times at 3 h and 125-175 times at 5 h) but the elimination half-life of morphine in the CSF was similar to that in plasma. The lumbar approach was used with similar efficacy as reported for thoracic administration. Side effects were few and nonsignificant. Epidural morphine administration evidently results in a dose-dependent analgesia, as well as concentrations in the CSF that are considerably higher than in plasma. With similar elimination half-lives for morphine in CSF and plasma, the long analgetic duration probably depends on the locally high morphine concentrations achieved. For safety purposes, one may use the lumbar approach to the epidural space even for thoracic pain without reducing the efficacy.